0 f HEALTIA, EDUCATI N', AND ..L.FARE ublic, ce D p NATIONAL INSTITUTES OF H'EALTH- irt stitpw.,nno 10 December 1957 NATIOWSL INSrIVrt Cir 14INTAL 124'AVM ACCICTiom RISRAMCi4 CtHTtA U.S. Fu@L@te 14CALtM SIRVICC HoSrfrAL P. 0, Box 2000 Lillmr.?**, Kltf4TuCXY .. .... I am enclosing-copy of a report ',Effect of Epinephrine on 2 the LSD Reaction. You will notice that we were unable to either accentuate or inhibit the LSD reaction by injection of o.4-o.6 mg. epinephrine /70 kg-. subcutaneously. Taken tn.conjunction with.our failure to block'the mental effects of LSD with Dibenzyline, 1 feel that these data are a further indication that the'adenergic hypothesis of the LSD reaction2 must be questioned rather strenuously. Prelimi.,iary assessment of four materials received from the Sandoz Company has now been completed. Three of the materials proved to be psychotomimetic agents, though weaker than LSD. The doses approximately ectiivalent to i.0-1.5 mcg./kg. of LSD are: LSM, 6-9 mcg*@.4-g.; DA.,vi-57.1 10-15 mcg.7kg@; LPD-824, 10-15 ricg./kg. A more extensive study of these three materials Is now underway. DLO-57 did not induce any psychotomimetic changes, even in doses of 100 mcg./kg. A further direct investigation of this particular compound is therefore being dropped. 2 Possibly, potential cross-tolerance between It and LSD might be studied at some future date. I am enclosing thermofaxconles of material concern!ng o*,.rer LSD cok-6._@erars which have been'forwarded to me by the Sandoz Company. Please-let us 1,.now if there Is any way in which we can assist you with your program. 4 Yours very sir@cerely H M.D. Director El: lw' Enclosures